Regencell Bioscience (RGC) has had the highest return since February 28, 2022 by a large-cap US stock, returning 3,064.2%.
| ASSET | % RETURN |
|---|---|
Regencell Bioscience (RGC) | 3,064.17% |
Celestica (CLS) | 2,383.91% |
EXACT Sciences (EXAS) | 2,299.3% |
Modine Manufacturing (MOD) | 2,095.4% |
Vertiv (VRT) | 1,927.7% |
Sandisk (SNDK) | 1,901.11% |
Comfort Systems USA (FIX) | 1,602.43% |
Sterling Construction (STRL) | 1,348.14% |
Ast Spacemobile (ASTS) | 1,230.75% |
FTAI Aviation (FTAI) | 1,200.57% |
Palantir Technologies (PLTR) | 1,141.3% |
Carpenter Technology (CRS) | 969.02% |
TechnipFMC (FTI) | 957.18% |
YPF Sociedad Anonima (YPF) | 944.34% |
BridgeBio Pharma (BBIO) | 827.12% |
Lumentum (LITE) | 727.96% |
Summit Therapeutics (SMMT) | 675.2% |
TTM Technologies (TTMI) | 669.98% |
Nebius (NBIS) | 661.51% |
Western Digital (WDC) | 652.99% |
Vistra Energy (VST) | 645.47% |
NVIDIA (NVDA) | 640.84% |
Rocket Lab USA (RKLB) | 610.7% |
Insmed (INSM) | 606.83% |
GE Vernova LLC (GEV) | 586.84% |
Large-cap stocks are treated as having a market cap of $10B+.
